ESAT-6 subunit vaccination against Mycobacterium tuberculosis

Infection and Immunity

Volumn 68, Issue 2, 2000, Pages 791-795

  Brandt, Lise ^a   Elhay, Martin ^a,b   Rosenkrands, Ida ^a   Lindblad, Erik B ^a   Andersen, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b CSL LIMITED   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BCG VACCINE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; PHOSPHORYL LIPID A; VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

ACYLTRANSFERASES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; DDT; FEMALE; LIPID A; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; VACCINATION;

EID: 0033979229     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.2.791-795.2000     Document Type: Article

References (42)

1. Alving, C. R. 1993. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 187:430-446.
2. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536-2544.
3. Andersen, P. 1997. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45:115-131.
4. Andersen, P., D. Askgaard, A. Gottschau, J. Bennedsen, S. Nagai, and I. Heron. 1992. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand. J. Immunol. 36:823-831.
5. Andersen, P., D. Askgaard, L. Ljungqvist, J. Bennedsen, and I. Heron. 1991. Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun. 59:1905-1910.
6. Andersen, P., D. Askgaard, L. Ljungqvist, M. W. Bentzon, and I. Heron. 1991. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect. Immun. 59:1558-1563.
7. Astiz, M. E., E. C. Rackow, J. G. Still, S. T. Howell, A. Cato, K. B. Von-Eschen, J. T. Ulrich, J. A. Rudbach, G. McMahon, R. Vargas, et al. 1995. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit. Care Med. 23:9-17.
8. Baldwin, S. L., C. D'Souza, A. D. Roberts, B. P. Kelly, A. A. Frank, M. A. Lui, J. B. Ulmer, K. Huygen, D. N. McMurray, and I. M. Orme, 1998. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:2951-2959.
9. Bosio, C. M., and I. M. Orme. 1998. Effective, nonsensilizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice. Infect. Immun. 66:5048-5051.
10. Brandt, L., T. Oettinger, A. Holm, and P. Andersen. 1996. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J. Immunol. 157:3527-3533.
11. Carozzi, S., M. Salit, A. Cantaluppi, M. G. Nasini, S. Barocci, S. Cantarella, and S. Lamperi. 1989. Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis. J. Clin. Microbiol. 27:1748-1753.
12. Elhay, M. J., and P. Andersen. 1997. Immunological requirements for a subunit vaccine against tuberculosis. Immunol. Cell Biol. 75:595-603.
13. Ewasyshyn, M., B. Caplan, A. M. Bonneau, N. Scollard, S. Graham, S. Usman, and M. Klein, 1992. Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine. Vaccine 10:412-420.
14. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
15. Good, M. F., Y. Zevering, J. Currier, and J. Bilsborough. 1993. 'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion. Parasite Immunol. 15:187-193.
16. Grun, J. L., and P. H. Maurer. 1989. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cell. Immunol. 121:134-145.
17. Harboe, M., H. G. Wiker, G. Ulvund, A. S. Malin, H. Dockrell, A. Holm, M. C. Jørgensen, and P. Andersen. 1998. B-cell epitopes and quantification of the ESAT-6 protein of Mvcobacterium tuberculosis. Infect. Immun. 66: 717-723.
18. Horwitz, M. A., B. W. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530-1534.
19. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J. P. Van-Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
20. Jacobs, D. M. 1981. Immunomodulatory effects of bacterial lipopolysaccharide. J. Immunopharmacol. 3:119-132.
21. Kamath, A. T., C. G. Feng, M. Macdonald, H. Briscoe, and W. J. Britton. 1999. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun. 67:1702-1707.
22. Li, Z., A. Howard, C. Kelley, G. Delogu, F. Collins, and S. Morris. 1999. Immimogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect. Immun. 67:4780-4786.
23. Lindblad, E. B., M. J. Elhay, R. Silva, R. Appelberg, and P. Andersen. 1997. Adjuvant modulation of immune response to tuberculosis subunit vaccines. Infect. Immun. 65:623-629.
24. Ljungqvist, L., A. Worsaae, and I. Heron. 1988. Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect. Immun. 56:1994-1998.
25. Lozes, E., K. Huygen, J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, P. Vandenbussche, J. P. Van-Vooren, A. Drowart, J. B. Ulmer, and M. A. Liu. 1997. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15:830-833.
26. Martin, R. M., and A. M. Lew. 1998. Is IgG2a a good Th1 marker in mice? Immunol. Today 19:49.
27. Masihi, K. N., W. Lange, W. Brehmer, and E. Ribi. 1986. Immunobioiogical activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Int. J. Immunopharmacol. 8:339-345.
28. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481-1497.
29. Oukka, M., J. C. Manuguerra, N. Livaditis, S. Tourdot, N. Riche, I. Vergnon, P. Cordopatis, and K. Kosmatopoulos. 1996. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J. Immunol. 157:3039-3045.
30. Pal, P. G., and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781-4792.
31. Pathan, A., R. Brookes, H. Pritchard, R. Wilkinson, G. Pasvol, A. Hill, and A. Lalvani. 1998. Human T cell responses to the antigen ESAT-6 characterize a vaccine candidate and potential diagnostic test for tuberculosis. Immunology 95:90.
32. Pollock, J. M., and P. Andersen. 1997 Predominant recognition of the ESAT-6 protein in the first phase of infection with Mycobacterium bovis in cattle. Infect. Immun. 65:2587-2592.
33. Pollock, J. M., and P. Andersen. 1997. The potential of the ESAT-6 antigen secreted by virulent mycohacteria for specific diagnosis of tuberculosis. J. Infect. Dis. 175:1251-1254.
34. Ravn, P., A. Demissie, T. Eguale, H. Wondwosson, D. Lein, H. Amoudy, A. S. Mustafa, A. K. Jensen, A. Holm, I. Rosenkrands, F. Oftung, J. Olobo, C. F. von-Reyn, and P. Andersen. 1999. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179:637-645.
35. Ribi, E., T. J. Meyer, I. Azuma, R. Parker, and W. Brehmer. 1975. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent Mycobacterium tuberculosis. Cell. Immunol. 16:1-10.
36. Roberts, A. D., M. G. Sonnenberg, D. J. Ordway, S. K. Furney, P. J. Brennan, J. T. Belisle, and I. M. Orme. 1995. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85:502-508.
37. Rudbach, J. A., D. A. Johnson, and J. T. Ulrich. 1995. Ribi adjuvants: chemistry, biology and utility in vaccines for human and veterinary medicine, p. 287-313. In D. E. S. Stewart-Tull (ed.), The theory and practical application of adjuvants. John Wiley & Sons Ltd., New York, N.Y.
38. Stanfield, J. P., D. Gall, and P. M. Bracken. 1973. Single-dose antenatal tetanus immunisation. Lancet 1:215-219.
39. Stoute, J. A., M. Slaoui, D. G. Heppner, P. Momin, K. E. Kester, P. Desmons, B. T. Wellde, N. Garcon, U. Krzych, M. Marchand, W. R. Ballou, and J. D. Cohen. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N. Engl. J. Med. 336:86-91.
40. Ulrich, J. T., and K. R. Myers. 1995. Monophosphoryl lipid A as an adjuvant. Past experiences and new directions. Pharm. Biotechnol. 6:495-524.
41. Ulrichs, T., M. E. Munk, H. Mollenkopf, S. Behr-Perst, R. Colangeli, M. L. Gennaro, and S. H. Kaufmann. 1998. Differential T cell responses to Mycobacterium tuberculosis ESAT-6 in tuberculosis patients and healthy donors. Eur. J. Immunol. 28:3949-3958.
42. Worsaae, A., L. Ljungqvist, and I. Heron. 1988. Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J. Clin. Microbiol. 26: 2608-2614.